Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
- HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on November 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 10/29/2024
|
2 Instruments Stocks to Watch From a Challenging Industry
- The Zacks Instruments - Scientific industry participants like MTD and HBIO are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
- 10/29/2024
|
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
- Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development
- 09/18/2024
|
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference
- HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Small Cap Virtual Conference on September 18th, 2024, with a presentation time of 9:15 am ET.
- 09/05/2024
|
Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2024 Earnings Conference Call August 8, 2024 10:00 AM ET Company Participants Kathryn Flynn - Corporate Controller James Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Participants Paul Knight - KeyBanc Capital Markets Bruce Jackson - The Benchmark Company Christopher Sakai - Singular Research Operator Good day, and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. Earnings Conference Call.
- 08/11/2024
|
Harvard Bioscience Announces Second Quarter 2024 Financial Results
- HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2024.
- 08/08/2024
|
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
- HOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2024 before the market opens on August 8, 2024, and will hold a conference call to discuss the results at 10:00 a.m. Eastern Time.
- 08/02/2024
|
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
- HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
- 06/06/2024
|
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
- HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
- 05/23/2024
|
Electric school buses may yield significant health and climate benefits, cost savings
- Replacing diesel school buses with electric school buses may yield up to $247,600 in climate and health benefits per individual bus, according to a new study by researchers at Harvard T.H. Chan School of Public Health. The researchers found that these benefits—including fewer greenhouse gas emissions and reduced rates of adult mortality and childhood asthma—and their associated savings are strongest in large cities and among fleets of old (2005 and before) buses.
- 05/20/2024
|
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
- HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET. The Company will also be hosting one-on-one meetings with investors in conjunction with the Conference.
- 05/16/2024
|
Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Frank DiLorenzo - Singular Research Operator Good day, and thank you for standing by. Welcome to the Q1 2024 Harvard Bioscience Inc. Earnings Conference Call.
- 05/07/2024
|
Harvard Bioscience (HBIO) Q1 Earnings Match Estimates
- Harvard Bioscience (HBIO) came out with quarterly earnings of $0.02 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.06 per share a year ago.
- 05/07/2024
|
Harvard Bioscience Announces First Quarter 2024 Financial Results
- Strong gross margin performance and focus on efficiency to support ongoing investments in growth Strong gross margin performance and focus on efficiency to support ongoing investments in growth
- 05/07/2024
|
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
- HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 04/29/2024
|
Watch These 5 Technology Stocks for Q1 Earnings: Beat or Miss?
- Here is a sneak peek into how five technology stocks, MANH, MSCI, AEYE, HBIO and TXN, are expected to fare in their quarterly results slated to be released on Apr 23.
- 04/22/2024
|
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
- HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth.
- 04/09/2024
|
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference
- HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be held virtually in March 2024. Joining him will be Jennifer Cote, the Company's Chief Financial Officer.
- 03/11/2024
|
Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q4 2023 Earnings Conference Call March 7, 2024 8:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President & Chief Executive Officer Jennifer Cote - Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Frank DiLorenzo - Singular Research Operator Good morning, and thank you for standing by. Welcome to Harvard Bioscience, Inc. Fourth Quarter 2023 Earnings Conference Call.
- 03/07/2024
|
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
- HOLLISTON, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31, 2023.
- 03/07/2024
|
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
- Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics
- 03/06/2024
|
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
- HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 02/27/2024
|
Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023
- HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City.
- 11/20/2023
|
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
- HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company's Chief Financial Officer and Treasurer.
- 11/09/2023
|
Harvard Bioscience, Inc. (HBIO) Q3 2023 Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Dave Sirois - Director, Corporate Accounting & SEC Reporting James Green - Chairman, President & Chief Executive Officer Jennifer Cote - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Operator Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.
- 11/07/2023
|
Harvard Bioscience Announces Third Quarter 2023 Financial Results
- HOLLISTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2023.
- 11/07/2023
|
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
- HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) conference from November 12-15, 2023, in Washington, D.C.
- 11/06/2023
|
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
- HOLLISTON, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2023 before the market opens on November 7, 2023, and will hold a conference call to discuss the results at 8:00 a.m.
- 10/30/2023
|
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
- Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI)
- 09/18/2023
|
Harvard Bioscience: Looking To Reload After Post-Q2 Earnings Sell-Off
- Harvard Bioscience's Q2 earnings showed a slight miss on EPS and revenue, causing a decline in the stock price. The company is committed to improving its product portfolio and has observed increased traction from new products launched last year. Despite the earnings miss, Harvard Bioscience is still pulling in profit and experiencing growth, with updated guidance for 2023 showing expected revenue increase.
- 09/07/2023
|
Harvard Bioscience, Inc. (HBIO) Q2 2023 Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2023 Earnings Conference Call August 8, 2023 8:00 AM ET Company Participants Dave Sirois - Director, Corporate Accounting & SEC Reporting James Green - Chairman, President & Chief Executive Officer Jennifer Cote - Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Operator Thank you for standing by and welcome to Harvard Bioscience's Second Quarter 2023 Earnings Call. [Operator Instructions] I would now like to hand the call over to your host, David Sirois, Director of SEC Reporting.
- 08/08/2023
|
Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates
- Harvard Bioscience (HBIO) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.
- 08/08/2023
|
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
- HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the company's Chief Financial Officer and Treasurer.
- 08/03/2023
|
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
- HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2023 before the market opens on August 8, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 07/27/2023
|
Here's Why Momentum in Harvard Bioscience (HBIO) Should Keep going
- Harvard Bioscience (HBIO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
- 06/21/2023
|
Harvard Bioscience: Rally In Shares Losing Steam
- Today, we take our first look at medical device concern Harvard Bioscience, Inc. The shares have doubled over the past few months on better-than-expected results and improving cash flow. Can the rally continue? An investment analysis follows in the paragraphs below.
- 06/20/2023
|
3 Instruments Stocks to Watch From a Prospering Industry
- The Zacks Instruments - Scientific industry participants like Harvard Bioscience (HBIO), Mettler-Toledo (MTD) and Waters (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
- 06/16/2023
|
5 High-Flying Tech Stocks With Solid Growth Potential
- Investors should consider stocks like Harvard Bioscience (HBIO), MicroStrategy (MSTR), Meta Platforms (META), InterDigital (IDCC), and Weave Communications (WEAV) in their portfolio if they want to outperform the broader market.
- 05/24/2023
|
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
- HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Micro Cap Virtual Conference taking place on May 10th, 2023.
- 05/02/2023
|
Why Harvard Bioscience Stock Rose This Week
- Harvard Bioscience's shares are up more than 105% so far this year. The company is seeing strong sales from its equipment to aid in CRISPR gene-editing.
- 04/27/2023
|
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
- HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April 25, 2023, and will hold a conference call to discuss the results at 9:00 a.m. Eastern Time.
- 04/17/2023
|
Harvard Bioscience: Stock To Rise On Long-Term Growth And Attractive Valuation
- Harvard Bioscience is seeing strong order growth for its improved product portfolio. Harvard Bioscience has strong expected earnings growth for 2023 and 2024.
- 03/26/2023
|
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
- HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on March 22-23, 2023.
- 03/16/2023
|
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
- HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023.
- 03/16/2023
|
Harvard Bioscience, Inc. (HBIO) Q4 2022 Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q4 2022 Earnings Call Transcript March 9, 2023 8:00 AM ET Company Participants Dave Sirois - Director, Corporate Accounting & SEC Reporting Jim Green - Chairman of the Board, President & Chief Executive Officer Jennifer Cote - Interim Chief Financial Officer Conference Call Participants Bruce Jackson - Benchmark Company Harrison Schrage - KeyBanc Operator Good day, and thank you for standing by. Welcome to the Harvard Bioscience Fourth Quarter 2022 Earnings Conference Call.
- 03/09/2023
|
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
- HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on March 9, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 02/28/2023
|
10 Stocks Under $10 for 2023
- Welcome to January! The season of holiday gifts
- 01/03/2023
|
Harvard Bioscience, Inc. (HBIO) Q3 2022 Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants David Sirois - Director, Corporate Accounting & SEC Reporting James Green - President, CEO & Chairman Michael Rossi - CFO Conference Call Participants Paul Knight - KeyBanc Capital Markets Bruce Jackson - The Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Harvard Bioscience Third Quarter 2022 Earnings Call.
- 11/12/2022
|
Harvard Bioscience (HBIO) Reports Q3 Loss, Misses Revenue Estimates
- Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -120% and 3.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/08/2022
|
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
- HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2022 after the market closes on November 8, 2022, and will hold a conference call to discuss the results at 4:30 p.m. Eastern Time.
- 11/02/2022
|
Harvard Bioscience: Undervalued, Underfollowed, And A Perfect Candidate For My 'Bio Boom' Portfolio
- Harvard Bioscience is a small-cap life-science technology company that is trading at a significant discount after falling ~67% over the past twelve months despite the ticker's significant upside potential. I believe the market-wide sell-off has provided me with an opportunity to grow HBIO into a larger element of my Compounding Healthcare “Bio Boom” Portfolio.
- 10/25/2022
|
Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q2 2022 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants David Sirois - Director of Corporate Accounting & SEC Reporting Jim Green - President & Chief Executive Officer Mike Rossi - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Paul Knight - KeyBanc Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q2 2022 Harvard Bioscience, Inc. Earnings Conference Call.
- 08/07/2022
|
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
- HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on August 4, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 07/26/2022
|
Harvard Bioscience (HBIO) Loses 35.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Harvard Bioscience (HBIO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- 05/16/2022
|
Harvard Bioscience, Inc. (HBIO) CEO James Green on Q1 2022 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants David Sirois - Director of Corporate Accounting & SEC Reporting James Green - President & Chief Executive Officer Michael Rossi - Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Capital Markets Tim Chiang - Northland Capital Markets Bruce Jackson - The Benchmark Company Operator Good morning, ladies and gentlemen. Thank you for standing by and welcome to the Harvard Bioscience, Inc. First Quarter 2022 Earnings Conference Call.
- 05/04/2022
|
Harvard Bioscience (HBIO) Q1 Earnings and Revenues Lag Estimates
- Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2022
|
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
- HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2022 before the market opens on May 4, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 04/21/2022
|
Harvard Bioscience - Dressed Up And Waiting For A Suitor
- Harvard Bioscience (HBIO) is a small-cap, life-science technology company that is underfollowed.
- 03/15/2022
|
Harvard Bioscience, Inc. (HBIO) CEO James Green on Q4 2021 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (HBIO) CEO James Green on Q4 2021 Results - Earnings Call Transcript
- 03/08/2022
|
Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET
- HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on March 8, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 02/21/2022
|
Harvard Bioscience, Inc. (HBIO) CEO James Green on Q3 2021 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (HBIO) CEO James Green on Q3 2021 Results - Earnings Call Transcript
- 11/03/2021
|
Harvard Bioscience (HBIO) Q3 Earnings Meet Estimates
- Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0.00% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/03/2021
|
Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
- HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on November 3, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 10/18/2021
|
Week 33 MDA Breakout Stocks - August 2021: Short-Term Picks To Give You An Edge
- Two new Breakout Stocks for Week 32 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. Following the Momentum Gauges®, the portfolio is up +49.8% YTD with a record 18 out of 32 weeks this year in negative market conditions above the 40 MG level.
- 08/16/2021
|
Harvard Bioscience, Inc. (HBIO) CEO James Green on Q2 2021 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (HBIO) CEO James Green on Q2 2021 Results - Earnings Call Transcript
- 08/08/2021
|
Harvard Bioscience (HBIO) Tops Q2 Earnings and Revenue Estimates
- Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 20.00% and 6.56%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/05/2021
|
Harvard Bioscience Announces Second Quarter 2021 Financial Results
- Strong double digit revenue growth, solid margin performance despite global supply chain disruptions
- 08/05/2021
|
Are You Looking for a Top Momentum Pick? Why Harvard Bioscience (HBIO) is a Great Choice
- Does Harvard Bioscience (HBIO) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 07/02/2021
|
Harvard Bioscience (HBIO) Is a Great Choice for "Trend" Investors, Here's Why
- Harvard Bioscience (HBIO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
- 07/02/2021
|
4 Breakout Stocks You Must Add Right Away to Your Portfolio
- The logic behind this strategy for stock selection is to identify stocks that are trading within a narrow band.
- 06/30/2021
|
7 Stocks To Buy Right Now Under $10
- Value investors look for inexpensive stocks that have growth potential. They often see low cost stocks as being on sale or undervalued.
- 06/08/2021
|
5 Stocks with Solid Track Records at Attractive Prices
- This is probably the time to focus on fundamentals because we don't want to overpay for stocks in a buoyant market.
- 06/03/2021
|
Surging Earnings Estimates Signal Upside for Harvard Bioscience (HBIO) Stock
- Harvard Bioscience (HBIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 06/03/2021
|
Harvard Bioscience, Inc. (HBIO) CEO James Green on Q1 2021 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (HBIO) CEO James Green on Q1 2021 Results - Earnings Call Transcript
- 05/09/2021
|
Harvard Bioscience Announces First Quarter 2021 Financial Results
- Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins
- 05/06/2021
|
Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
- HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
- 04/19/2021
|
Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q4 2020 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q4 2020 Results - Earnings Call Transcript
- 03/10/2021
|
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
- HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on March 10, 2021, and will hold a conference call to discuss the results on March 10, 2021 at 8:00 a.m. Eastern Time.
- 02/18/2021
|
Harvard Bioscience Announces New Credit Facility
- HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (“Harvard Bioscience”) today announced the refinancing of its debt with the closing of a new $65 million credit facility (the “Refinancing”). Proceeds from the new facility will be used to retire existing debt and pay related fees and expenses. The Refinancing significantly reduces borrowing costs while increasing operating flexibility through less restrictive financial covenants and access to higher levels of revolver borrowings.
- 12/22/2020
|
Harvard Bioscience to attend Benchmark's 9th Annual Discovery One-on-One Conference
- HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in The Benchmark Company's 9th Annual Discovery One-on-One Conference. The virtual event will take place on Wednesday, November 18, 2020 with virtual investor meetings held throughout the day.
- 11/16/2020
|
Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q3 2020 Results - Earnings Call Transcript
- Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q3 2020 Results - Earnings Call Transcript
- 11/07/2020
|
NBC's Welker sharp in first turn as debate moderator
- Moderator Kristen Welker, with the help of an offstage mute button, helped give Americans a substantive head-to-head debate over leadership that had been missing during the presidential campaign
- 10/23/2020
|
Human Rights Is the Next Frontier of Sustainable Investing
- Your investment manager may be signing a pledge to urge companies you own to address any human rights problems, anticipate them, and remedy them.
- 10/22/2020
|
As Stimulus Check Uplift Wanes, Vulnerable Workers Are at Risk
- Economists are concerned that low wage workers are getting pushed deeper into poverty.
- 10/22/2020
|
Harvard Posts $10 Million Loss With More Financial Strife Ahead - BNN Bloomberg
- Harvard University posted a $10 million operating loss in fiscal 2020 and said it’s likely revenue will decline for a second straight year due to the Covid-19 crisis.
- 10/22/2020
|
Commodity Trader Bet on Longer Human Lifespans
- Paul Glenn, a commodity trader, regarded human life as ‘wonderful but tragically brief.’ He tried to extend it by donating much of his fortune to research into the biology of aging. He has died at age 89.
- 10/22/2020
|
Why Tesla's 20-million electric vehicle goal could next take Elon Musk to India
- As Tesla ramps electric vehicle production in China and constructs a new auto factory in Germany, Elon Musk envisions 20-million EVs from the company. Getting there could mean going to India next.
- 10/22/2020
|
List of Ivy League schools ranked in 2020
- This ⭐LIST OF IVY LEAGUE SCHOOLS⭐ comprises these eight powerhouse universities. Apply to one of the schools today, and you are guaranteed quality education.
- 10/22/2020
|
Precisely Delivers First End-to-End Data Integrity Suite for Confident Business Decisions
- Precisely, the global leader in data integrity, today announced the Precisely Data Integrity Suite, a modular, interoperable suite that provides maxim
- 10/22/2020
|
Uber CEO says prices could double if drivers become employees, but this economist isn’t buying it
- Chief Executive Dara Khosrowshahi said Tuesday that California residents could see the costs of ride-sharing as much as double, but UC Berkeley professor and...
- 10/21/2020
|
Red Hat Forum Asia Pacific 2020 Presents New Perspectives for Businesses to Lead with Open Hybrid Cloud
- Red Hat, Inc., the world's leading provider of open source solutions, today announced that market leaders, innovators and Red Hat partners will be con
- 10/21/2020
|
Nearly a Quarter of New York City Transit Workers May Have Been Infected With Covid-19, Study Says
- New York City subway and bus workers might have been infected by the new coronavirus at rates higher than previously thought, a survey says.
- 10/20/2020
|
Why those highly paid investing pros do worse than a 401(k) committed to a boring stock index fund
- High fees take a toll on performance, no matter how bright and brilliant you are, writes Michal Edesess.
- 10/20/2020
|
Confusing Before-The-Fact Strategy With After-The-Fact Outcome
- Individual decisions can be badly thought through, and yet be successful, or exceedingly well thought through, but be unsuccessful, because the recognized possibility of failure in fact occurs.
- 10/20/2020
|
10 million snowblowers? Last-ditch ideas to save the Arctic ice
- Some of the solutions sound fantastical – but their proponents argue that there are precious few other options
- 10/20/2020
|
The 10 best global universities of 2021, according to U.S. News
- For the ranking, U.S. News analyzed the data of nearly 1,500 schools from 86 countries across 13 different variables.
- 10/20/2020
|
Lagarde Schedules Her Priorities For The ECB's New Monetary Policy Framework
- Conflating the COVID-19 pandemic with Climate Change may be the best way for Christine Lagarde to schedule her MMT priorities for the ECB’s new monetary policy framework.
- 10/19/2020
|
Deglobalisation, disrupted education and debt: economic policy challenges following the pandemic Speech at Harvard University
|
Anti-lockdown advocate appears on radio show that has featured Holocaust deniers
- Dr Martin Kulldorff discussed ‘Great Barrington declaration’ letter on Richie Allen Show
- 10/19/2020
|
If you find yourself doomscrolling your way through social media, help is at hand | Rhiannon Lucy Cosslett
- Reconnecting with yourself and others may be the cure, says Guardian columnist Lucy Rhiannon Cosslett
- 10/19/2020
|
Ivy League Basketball Season In Jeopardy Amid Covid-19 Pandemic, With Harvard Not Expected To Play
- Many of the Ivy League’s coaches remain optimistic a basketball season can happen, but multiple league sources say Harvard is not expected to play this year, and whether the league would hold a season with fewer than its full eight teams remains uncertain.
- 10/19/2020
|
Totalitarianism on Campus | National Review
- Two recent incidents at Harvard and Middlebury show the growing intolerance of the woke.
- 10/17/2020
|
Scammers seize on US election, but it's not votes they want
- PROVIDENCE, R.I. (AP) - The email from a political action committee seemed harmless: if you support Joe Biden, it urged, click here to make sure you're registered to vote.
But Harvard University graduate student Maya James did not click. Instead, she Googled the name of the soliciting PAC. It didn't exist -- a clue the email was a phishing scam from swindlers trying to exploit the U.S. presidential election as a way to steal peoples' personal information.
"There was not a trace of them," James, 22, said. "It was a very inconspicuous email, but I noticed it used very emotional language, and that set off alarm bells." She deleted the message, but related her experience on social media to warn others.
American voters face an especially pivotal, polarized election this year, and scammers here and abroad are taking notice - posing as fundraisers and pollsters, impersonating candidates and campaigns, and launching fake voter registration drives. It's not votes they're after, but to win a voter's trust, personal information and maybe a bank routing number.
The Federal Bureau of Investigation, the Better Business Bureau and cybersecurity experts have recently warned of new and increasingly sophisticated online fraud schemes that use the election as an entry, reflecting both the proliferation of political misinformation and intense interest in this year's presidential and Senate races.
"Psychologically, these scams play to our desire to do something - to get involved, to donate, to take action," said Sam Small, chief security officer at ZeroFOX, a Baltimore, Maryland-based digital security firm.
Online grifters regularly shift tactics to fit current events, whether they are natural disasters, a pandemic or an election, according to Small. "Give them something to work with and they'll find a way to...
- 10/17/2020
|
Scanning Electrochemical Microscopy Market | Growth to Accelerate at a CAGR of Almost 7% Through 2024 | Technavio
- The Global Scanning Electrochemical Microscopy (SECM) Market will grow by $ 41.90 mn during 2020-2024
- 10/17/2020
|
Massive Solar Panel Array Powers Pedigree Ovens and The Pound Bakery Pet Treat Manufacturing Plant
- Pedigree Ovens and The Pound Bakery pet treat manufacturer installs 200,000 sq. ft. solar panel array to power 100% of their energy needs.
- 10/15/2020
|
Fact check: Misleading meme features mixture of false claims and disparaging opinion about Barack Obama
- Shared thousands of times by users on social media, a meme makes a series of allegations about U.S. President Barack Obama. Presenting its claims as “facts”, the meme contains a series of fabricated, false claims about the 44th president of the United States, mixed with...
- 10/14/2020
|
The Verdict on Trump’s Economic Stewardship, Before Covid and After
- Through last year, growth and a strong job market lifted many Americans, including less-skilled workers. The pandemic reversed that, and the path back to prosperity is uncertain.
- 10/14/2020
|
Chris Killip, hard-hitting photographer of Britain's working class, dies aged 74
- Influential artist, hailed by Martin Parr as a ‘key player’ in British photography, captured human dignity amid industrial decline in England’s north-east
- 10/14/2020
|
Airborne radioactivity increases downwind of fracking, study finds
- Particles released by drilling could damage the health of nearby residents, say scientists
- 10/13/2020
|
Ivy League colleges shun Warren Buffett’s advice
- A look at America's top 12 long-term university endowments
- 10/13/2020
|
Avoid the back-and-forth of meeting management with this smart tool
- Meet easily and save time with this handy meeting scheduler
- 10/13/2020
|
Energy Transfer: What's The Worst Thing That Can Happen? (NYSE:ET)
- A distribution cut is possible but not likely. The Environmental Impact Statement is unlikely to find any environmental concerns.
- 10/13/2020
|
Harvard timelapse map reveals how 'untamed' covid spread in the US
- As broad a swath of the US as ever is now in the red as high-risk for COVID-19 spread, with more than 25 people per 100,000 residents testing positive each day in 11 states, the new animation reveals.
- 10/12/2020
|
The Alec Hogg Show: Brutally honest Rob Hersov on Ruperts, coming home; unseating ANC - BizNews.com
- Wealthy, educated and just turned 60, Rob Hersov is on a mission to help fix South Africa, something you’ll hear plenty about in this interview.
- 10/12/2020
|
COVID-19 antibodies last at least three months; so do symptoms for many
- COVID-19 antibodies last at least three months; so do symptoms for many
- 10/12/2020
|
Trump to return to campaign trail despite unanswered questions about his health
- President Donald Trump on Sunday declared he was ready to return to the campaign trail despite unanswered questions about his health on the eve of a Florida...
- 10/11/2020
|
Scientist accused of hiding Chinese funds sues Harvard, saying it abandoned him
- NEW YORK (NYTIMES) - Charles Lieber, a prominent scientist, filed a lawsuit against Harvard on Friday (Oct 9), asserting that the university abandoned him, in a breach of contract, after the Justice Department charged Lieber with concealing research funds he had received from a Chinese state-run initiative.. Read more at straitstimes.com.
- 10/10/2020
|
Teaching Our Students to ‘Cancel’
- Commentary You’ll hear that cancel culture isn’t real. You’ll hear that that the phrase is just a way ...
- 10/10/2020
|
‘The Upswing’ Review: Bowling Alone No More?
- The author of a classic study of social fragmentation makes the case for coming back together.
- 10/09/2020
|
Professor Charged in China Case Sues Harvard Over Legal Fees
- BOSTON—A Harvard University professor charged with hiding his ties to a Chinese-run recruitment program sued the Ivy League school on Friday over its refusal to pay his legal defense costs, accusing it of “turning its back on a dedicated faculty member."
- 10/09/2020
|
Professor charged in China case sues Harvard over legal fees
- A Harvard University professor charged with hiding his ties to a Chinese-run recruitment program has sued the Ivy League school over its refusal to pay his legal defense costs
- 10/09/2020
|
Professor charged in China case sues Harvard over legal fees
- BOSTON (AP) - A Harvard University professor charged with hiding his ties to a Chinese-run recruitment program sued the Ivy League school on Friday over its refusal to pay his legal defense costs, accusing it of "turning its back on a dedicated faculty member."
Charles Lieber, who was chair of the department of chemistry and chemical biology, was arrested in January at his office on campus and charged in federal court with lying about his involvement in China's Thousand Talents Plan, a program designed to lure people with knowledge of foreign technology and intellectual property to China.
Lieber's attorney, Marc Mukasey, has promised to mount a vigorous defense and has said that "when justice is done, Charlie's good name will be restored."
The lawsuit says Harvard denied Lieber's request to advance his defense costs, hasn't agreed to reimburse him at all and is demanding that he essentially "prove definitively his innocence to Harvard" before his trial to get financial help.
"Employees who find themselves accused of wrongdoing rely on their employers' promises to pay their defense costs," the complaint says.
"Instead of following suit, and supporting their long-standing, well-respected employee, Harvard has placed Professor Lieber on administrative leave, publicly denounced him, improperly characterized the charges against him, and permanently and falsely associated him with academic espionage, forever harming his reputation," it said.
A Harvard spokesperson declined to comment on the lawsuit. The university is cooperating with authorities in the criminal case.
The lawsuit accuses Harvard of breach of contract and says the school's failure to follow through will leave Lieber, who was diagnosed years ago with a blood cancer, and his family...
- 10/09/2020
|
Harvard Professor Sues School for Legal Expenses to Fight China Charges
- Scientist Charles Lieber is accused of misleading the Defense Department and the National Institutes of Health about taking part in a Chinese government talent-recruitment program, while the U.S. agencies spent more than $15 million to fund his research group.
- 10/09/2020
|
Recetarios medievales y tarjetas perforadas: la historiadora que lleva 50 años creando el gran archivo culinario de Internet
- Barbara K. Wheaton tiene 89 años y ha dedicado más de la mitad de su vida a construir The Sifter, una base de datos ahora disponible online con la que aspira a registrar la historia universal de la cocina
- 10/09/2020
|
Herd immunity letter signed by fake experts including 'Dr Johnny Bananas'
- Open letter calling for new Covid-19 strategy also signed by ‘Cominic Dummings’
- 10/09/2020
|
Harvard Business School Names New Dean
- The 112-year-old institution turns to veteran Srikant Datar to steer it through the coronavirus pandemic that has upended much of higher education.
- 10/09/2020
|
Harvard names Srikant Datar the new dean of its business school - The Boston Globe
- Harvard has promoted professor Srikant Datar to be the next dean of Harvard Business School, taking over for Nitin Nohria when he steps down at the end of the year.
- 10/09/2020
|
Wondering how much your Social Security check will increase next year?
- The Social Security Administration will soon set its COLA for 2021
- 10/09/2020
|
Medical workers are sacrificing themselves to protect us. Here's how we can help them | Norma Torres
- We need to support our frontline medical workers the same way we support military veterans and firefighter, writes California congresswoman Norma Torres
- 10/09/2020
|
What the Harvard endowment’s below-average grade can teach you about index funds and your investments
- Beating the market is tough — even for the best and brightest pros.
- 10/09/2020
|
How a wife-pimping con artist tricked a Harvard divinity professor
- In 2012, Karen L. King claimed to have discovered a new gospel. Where did she find it?
- 10/09/2020
|
Upside, downside, why the U.S. fiscal feud could make a difference
- Upside, downside, why the U.S. fiscal feud could make a difference
- 10/09/2020
|
2 scientists win Nobel chemistry prize for gene-editing tool
- The Nobel Prize in chemistry has been awarded to two researchers for a gene-editing tool that has revolutionized science by providing a way to alter DNA, the code of life
- 10/08/2020
|
Harvard spins off natural-resources team, to remain partner
|
US medical supply chains failed, and COVID deaths followed
- From the very moment the pandemic reached America’s shores, the country was unprepared
- 10/08/2020
|
Harvard endowment to spin off natural-resources team into separate investment firm
- Harvard University's endowment is spinning out its natural-resources team into a separate unit that will manage the endowment's portfolio of orchards, farms...
- 10/08/2020
|
Harvard Spins Out Natural-Resources Team, Ending Long Chapter at Endowment
- The university’s endowment has spun out its natural-resources team into an independent investment firm that will take over some of the endowment’s portfolio of orchards, farms and plantations.
- 10/08/2020
|
A mumps epidemic has a lot to teach colleges about reopening safely in the time of coronavirus - STAT
- A mumps outbreak that tore through several Massachusetts colleges in the spring of 2016 offers lessons for those facing Covid-19.
- 10/08/2020
|
Why herd immunity strategy is regarded as fringe viewpoint
- Scientists say idea of ‘focused protection’ for vulnerable people is very hard to achieve and likely to lead to even higher death toll
- 10/07/2020
|
Stop moaning about pampered politicians and fat-cat CEOs — 4 tweaks you can make now that can ripple through to bigger change
- Start with consciously splitting how you spend your money to help foster competition.
- 10/07/2020
|
Going Beyond Human Brains: Deep Learning Takes On Synthetic Biology
- DNA and RNA have been compared to "instruction manuals" containing the information needed for living "machines" to operate. But while electronic machines like computers and robots are designed from the ground up to serve a specific purpose, biological organisms are governed by a much messier, more c
- 10/07/2020
|
US medical supply chains failed, and COVID deaths followed
- From the very moment the pandemic reached America’s shores, the country was unprepared
- 10/07/2020
|
US medical supply chains failed, and COVID deaths followed
- From the very moment the pandemic reached America’s shores, the country was unprepared
- 10/07/2020
|
Employers ‘Ignoring Vital Information’ When Making Decisions About People
- Employers may be making poor decisions about their people due to unconsciously ignoring vital information about the workforce. Using that information
- 10/07/2020
|
Opinion | Trump, Covid and Reason
- A new statement by scientists explains how to live with the virus.
- 10/06/2020
|
US judge: IRS can't keep coronavirus money from inmates
- A U.S. judge says the IRS can’t keep withholding coronavirus relief payments from incarcerated people, potentially clearing the way for at least 80,000 checks totaling more than $100 million to be sent to people behind bars in the United States
- 10/06/2020
|
Opinion | Biden’s Tax Plan Would Spur Economic Growth
- Wealth would be shared more broadly, and even free-marketeers see the benefit of more revenue.
- 10/05/2020
|
Helping companies that ‘keep the country going’: Small businesses can narrow racial wealth gaps and save the U.S. economy, says microlender’s CEO
- Opportunity Fund lends to mostly women, minorities and immigrants who have trouble getting loans from commercial banks to start or grow their businesses.
- 10/02/2020
|
Push to bring coronavirus vaccines to the poor faces trouble
- An ambitious international project to deliver coronavirus vaccines to the world’s poorest people is facing potential shortages of money, cargo planes, refrigeration and vaccines themselves
- 10/01/2020
|
Push to bring coronavirus vaccines to the poor faces trouble
- An ambitious international project to deliver coronavirus vaccines to the world’s poorest people is facing potential shortages of money, cargo planes, refrigeration and vaccines themselves
- 10/01/2020
|
IMF scrambles as potential global debt crisis comes into view
- The International Monetary Fund of Thursday urged countries to take action to avoid a global debt crisis that outside experts think is inevitable.
- 10/01/2020
|
Nearly 3 in 10 Native American women work a front-line job, but they're far from receiving equal pay
- Native American women, on average, are paid approximately $0.60 for every dollar earned by White, non-Hispanic men.
- 10/01/2020
|
Opinion | Sex, Due Process and Amy Coney Barrett
- Three other appellate courts followed her 2019 Title IX opinion—a mark of her quality as a jurist.
- 09/30/2020
|
Here’s How Harvard Business School Plans to Advance Racial Equality
- The school has acknowledged past missteps involving race and said it would recruit more Black students and faculty.
- 09/30/2020
|
Do debates affect presidential elections? Not much. - Poynter
- They aren't worthless, though. Pew surveys going back to 1988 show voters find debates “useful” in making their decisions, but not pivitol.
- 09/30/2020
|
35,000 airline workers may lose their jobs tomorrow - Poynter
- Plus, Disney will lay off 28,000 workers, COVID-19 is canceling spring break 2021, a hospital cyberattack may be the biggest ever, and more.
- 09/30/2020
|
Jane Street Group LLC Acquires Shares of 67,237 Harvard Bioscience, Inc. (NASDAQ:HBIO)
- Jane Street Group LLC acquired a new stake in Harvard Bioscience, Inc. (NASDAQ:HBIO) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 67,237 shares of the medical instruments supplier’s stock, valued at approximately $209,000. A number of other large investors have also made changes to their positions in the business. Marshall Wace LLP […]
- 09/30/2020
|
Harvard endowment posts strong returns - The Boston Globe
- The coronavirus pandemic has underscored the importance of university endowments, and sharpened the wealth gap between those with resources and those without.
- 09/29/2020
|
Opinion | ‘It’s the Economy, Stupid.’ But Which One?
- Students discuss the big picture of the U.S. presidential election.
- 09/29/2020
|
Harvard's endowment posts 7.3% gain, edging out rival Yale for 2nd straight year
|
Harvard’s Endowment Logs 7.3% Return in Turbulent Market
- The performance for the fiscal year ended June ranks high among large endowments during a turbulent stretch in markets.
- 09/29/2020
|
Poll: Trump Gains 5 Points on Biden as Race Tightens
- President Trump has gained five points against Democratic presidential candidate Joe Biden in the national popular vote in less than a month.
- 09/29/2020
|
Harvard Endowment Gains 7.3%. Here’s Why the Largest College Funds Lag the Stock Market.
- U.S. college endowments are now reporting investment returns for the year ended June 30. Many of the largest funds have more investments in alternatives than in stocks and bonds.
- 09/29/2020
|
Constellation Pharmaceuticals: Myelofibrosis Treatment Win Can Still Happen - We'll Know Soon (NASDAQ:CNST)
- Constellation's lead candidate CPI-0610 has shown efficacy as a potential monotherapy or combo treatment alongside Jakafi, against myelofibrosis in a phase 2 trial.
- 09/29/2020
|
Fact check: Obama’s university years have been documented
- Shared over 22,000 times, a Facebook post alleges there are no records of former president Barack Obama’s university years. This longstanding claim is unfounded and has been debunked in the past.
- 09/28/2020
|
Opinion | Notable & Quotable: Noah Feldman, a Liberal for Amy Coney Barrett
- ‘We have a Supreme Court nominee who is a brilliant lawyer, a genuine and good person—and someone who holds views about how to interpret the law that I think are wrong.’
- 09/27/2020
|
Is Covid to blame for business closures or is it helping new startups? The answer is both | Gene Marks
- A report found that more than 100,000 restaurants have closed this year, but another says new business applications are up by 19%
- 09/27/2020
|
Dreading a dark winter lockdown? Think like a Norwegian
- Studies show people living in the Arctic Circle are armed with a mindset that helps combat the long ‘polar night’. It might come in handy for us all…
- 09/26/2020
|
BiomX: A Phage Platform Play (NYSEMKT:PHGE)
- BiomX is focused on large market opportunities using the unique approach of manipulating the microbiome utilizing phage therapy.
- 09/25/2020
|
Homebuilders: A V-Shaped Vendetta
- An antihero of the prior financial crisis, Homebuilders have seemingly been on a vendetta over the last six months, asserting themselves as the unexpected leader of the early post-pandemic recovery.
- 09/25/2020
|
Clover Biopharmaceuticals Announces Formation of a Global Scientific Advisory Board for its COVID-19 Vaccine Program
- Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on discovering and developing transformative biologic therapies and v
- 09/25/2020
|
Yale Endowment Gained 6.8%. The Fund Trailed U.S. Stocks and Bonds.
- Yale University’s endowment, one of the largest in the U.S. at $31.2 billion, is heavily allocated to alternative investments at the expense of traditional stocks.
- 09/24/2020
|
'Echo chamber': The percentage of Harvard's incoming class who identify as conservative plummets
- The percentage of incoming Harvard students who identify as conservative dropped by nearly 50% compared to the 2017 graduating class.
- 09/24/2020
|
John Spooner
- John D. Spooner is a best-selling author and managing director for investments at Morgan Stanley, where he oversees assets for more than 800 families all over the world.
- 09/24/2020
|
50 Years After Milton Friedman, Companies Wrestle With Wider Purpose
- The economist said the social responsibility of a business is to increase profits, but that view is increasingly being questioned.
- 09/24/2020
|
Tangential Flow Filtration (TFF) System Market by Manufacturers, Regions, Type and Application, Forecast to 2027
- Sep 24, 2020 (Profound via COMTEX) --
In this report, our team research the global Tangential Flow Filtration (TFF) System market by type, application,...
- 09/24/2020
|
Covid Risk, Online Classes Spur Drop in U.S. College Enrollments
- Covid Risk, Online Classes Spur Drop in U.S. College Enrollments
- 09/24/2020
|
‘Law & Leviathan’ Review: Self-Government Minus the Self
- Two Harvard professors—one from the left, the other from the right—defend the ‘morality’ of the administrative state.
- 09/23/2020
|
Inside Covid-19: Nearly half with Covid-19 and flu likely to die; can vaccines save us? Ep 89 - BizNews.com
- We look at whether vaccines are likely to save the world from the coronavirus and how speaking too loudly can facilitate the spread of Covid-19.
- 09/23/2020
|
Harvard Business School Pledges to Tackle Race Issues
- Harvard Business School said it would boost future enrollment of Black students, hire a chief diversity officer and give race and diversity issues a more prominent place in its case-study method of teaching.
- 09/23/2020
|
Battle of billboards rages between Jair Bolsonaro’s foes and followers
- The arm-wrestle underscores Brazil’s bitter political rupture over a leader critics consider an abomination and supporters a corruption-busting champion
- 09/23/2020
|
Sushant University collaborates with Harvard Business School Online | Business
- Sushant University, a top-notch education institution situated in the heart of Gurugram, collaborates with Harvard Business School Online to offer high-impact online courses to its students.
- 09/23/2020
|
Jacobs Levy Equity Management Inc. Takes $213,000 Position in Harvard Bioscience, Inc. (NASDAQ:HBIO)
- Jacobs Levy Equity Management Inc. bought a new stake in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 68,551 shares of the medical instruments supplier’s stock, valued at approximately $213,000. Jacobs Levy Equity Management Inc. owned about 0.18% […]
- 09/23/2020
|
COVID-19 Recovery Analysis: Amino Acid Analyzer For Industrial, Preclinical, And Clinical Usage Market | Increased Application In Drug Discovery Research to Boost the Market Growth | Technavio
- The Global Amino Acid Analyzer for Industrial, Preclinical, and Clinical Usage Market 2020-2024 will grow by $ 19.89 mn during 2020-2024
- 09/23/2020
|
RBG's granddaughter reveals how she dictated dying wish
- Ruth Bader Ginsburg's Harvard lawyer granddaughter Clara Spera has spoken for the first time about how she dictated the Supreme Court Justice's dying wish on her computer
- 09/22/2020
|
Global Preclinical Animal Telemetry Market: COVID-19 Business Continuity Plan | Evolving Opportunities with ADInstruments Pty Ltd. and BIOPAC Systems Inc. | Technavio
- The Global Preclinical Animal Telemetry Market will grow by $ 7.06 mn during 2020-2024
- 09/22/2020
|
Yale and Harvard researchers create site ranking COVID-19 dashboards
- The site We Rate COVID Dashboards was founded by researchers from major universities including Harvard and Yale as students started returning to campuses across the country.
- 09/21/2020
|
Milton Friedman told us greed was good — he was half right
- Friedman helped start a discussion that still isn't finished 50 years later.
- 09/21/2020
|
Suspected subway saboteur charged for causing train derailment: cops
- The man suspected of causing a Manhattan subway derailment by tossing metal construction debris onto the tracks was hit with a number of charges for the vandalism on Sunday night, police said. Deme…
- 09/21/2020
|
Fluidics for Preclinical, Life Science Research, and Clinical Applications Market: COVID-19 Business Continuity Plan | Evolving Opportunities With AMETEK Inc. and Blacktrace Holdings Ltd. | Technavio
- The Global Fluidics for Preclinical, Life Science Research, and Clinical Applications Market will grow by $ 1.38 bn during 2020-2024
- 09/21/2020
|
‘JFK’ Review: The Road to Camelot
- In this account of his political apprenticeship, JFK is depicted as intellectually adventurous, personally appealing—and ambitious.
- 09/20/2020
|
The meritocracy has had its day. How else to explain the rise of Dido Harding? | Nick Cohen
- Public service jobs once went to people who knew what they were doing. Boris Johnson would rather promote a courtier
- 09/19/2020
|
Ruth Bader Ginsburg: death of liberal justice gives Trump chance to reshape the US for generations
- Mitch McConnell says he will fill supreme court vacancy but Democrats including Obama cry foul, citing case of Merrick Garland
- 09/19/2020
|
Justice Ruth Bader Ginsburg remembered by entire generations of lawyers - The Boston Globe
- Ruth Bader Ginsburg built a remarkable career as a legal and cultural icon who used her intelligence and courage to fight fearlessly for social justice.
- 09/19/2020
|
Ruth Bader Ginsburg changed America long before she joined the supreme court | Moira Donegan
- She spent her extraordinary career fighting for women’s rights and ensuring the promise of the constitution applied to all
- 09/19/2020
|
Princeton faces federal inquiry after acknowledging racism
- The Trump administration has opened an investigation into racial bias at Princeton University, saying that the school’s recent acknowledgment of racism on campus amounts to an admission of discrimination
- 09/18/2020
|
‘If Then’ Review: Big Data’s Baby Steps
- How a 1960s company’s pitch to predict tomorrow heralded our algorithm-driven age.
- 09/18/2020
|
'Pandemic fatigue' leads to resurgence of coronavirus in Europe where cases surge to fresh records in France and Spain
- "Pandemic fatigue" has set in across parts of Europe where the outbreak, which appeared contained over the summer, is on the rise again in some countries that were hailed early on for stamping out massive outbreaks.
- 09/18/2020
|
Ruth Bader Ginsburg, A Champion For Women As Supreme Court Justice, Dies At 87
- Supreme Court Justice Ruth Bader Ginsburg died Friday following complications from pancreatic cancer, cutting short her intended tenure to age 90. At 87 years old, Ginsburg had...
- 09/18/2020
|
Which U.S. Colleges Are the Most Diverse?
- Public schools stand out in having student bodies from a wide range of backgrounds.
- 09/17/2020
|
2021 Best Colleges in America: Harvard Leads the University Rankings
- The Ivy League dominates this year’s Wall Street Journal/Times Higher Education College Rankings. But the future of U.S. universities has never been murkier.
- 09/17/2020
|
Report: Much needs doing to shield nursing homes from virus
- The Trump administration is claiming “resounding vindication” from an independent commission’s report on the coronavirus crisis in nursing homes
- 09/17/2020
|
Report: Much needs doing to shield nursing homes from virus
- The Trump administration is claiming “resounding vindication” from an independent commission’s report on the coronavirus crisis in nursing homes
- 09/17/2020
|
Senators Elizabeth Warren and Chuck Schumer say U.S. should immediately cancel $50,000 in student loans for millions of borrowers
- 'Even before the COVID–19 pandemic, the United States also faced a historic student loan crisis, which is currently holding back our struggling economy,'...
- 09/17/2020
|
Those who won't wear masks put us all at risk, but confrontation is not the answer | Eleanor Morgan
- It’s easy to feel angry towards those who don’t follow Covid-19 guidelines. Yet empathy is the key to changing people’s minds, says author Eleanor Morgan
- 09/17/2020
|
Harvard’s Admissions Policies Again in Spotlight as Appellate Court Hears Oral Arguments
- The school’s undergraduate-admissions practices were scrutinized as a federal appeals court heard oral arguments in a high-profile case about how race factors into decisions regarding acceptance offers.
- 09/16/2020
|
5 things you need to know about Asana’s direct listing
- “When we started the company, there was a question about whether this would be a category,” company CEO Dustin Moskovitz said on investor day. “It feels much...
- 09/15/2020
|
“No ha habido nada como el coronavirus en la historia de los sueños”
- Deirdre Barrett, profesora de Psicología en Harvard, lleva medio año analizando cómo la amenaza del covid-19 ha cambiado la manera en que soñamos
- 09/15/2020
|
Should You Talk About Your Mental Health With Your Boss?
- Some people are struggling with a feeling of being overwhelmed by an untenable work-life juggle
- 09/14/2020
|
Catherine Dulac récompensée pour avoir découvert les neurones de l’instinct parental
- Elle est distinguée par le Breakthrough Prize, prix scientifique créé par des entrepreneurs de la Silicon Valley, pour avoir découvert où se trouve l’instinct parental dans le cerveau de la souris.
- 09/14/2020
|
The top 5 national universities of 2021, according to U.S. News—and what it takes to get in
- For the first time, U.S. News considered student debt in their ranking
- 09/14/2020
|
Microdialysis Market: COVID-19 Business Continuity Plan | Evolving Opportunities With Amuza Inc. and Bioanalytical Systems Inc. | Technavio
- The Global Microdialysis Market will grow by $ 0.86 mn during 2020-2024
- 09/14/2020
|
Public health experts grew increasingly uncomfortable as Trump continued to minimize severity of coronavirus crisis
- President Trump’s public messaging was often at odds with that of scientists and medical professionals, but he had a louder megaphone.
- 09/13/2020
|
As Trump played down virus, health experts' alarm grew
- Public health officials were already warning Americans about the need to prepare for the coronavirus threat when, as it turns out, President Donald Trump was calling it “deadly stuff” in a private conversation in early February
- 09/13/2020
|
Public health specialists criticize Trump administration over reports it interfered with CDC studies
- "I think that MMWR are still trying to get the information out there, but certainly now, I will start reading with a degree of skepticism," Dr. Carlos Del Rio, an infectious disease specialist at Emory University.
- 09/12/2020
|
OHIRI: Lion of Harvard - Vanguard News
- As a fresh man at Harvard, he stunned the combined Oxford/Cambridge University team in a competition against Harvard/ Yale Universities.
- 09/12/2020
|
"No hay suficiente información para saber cuál será el escenario definitivo"
- Miguel Hernán (Madrid, 1970) es otro de esos cerebros fugados que no han sido profetas en su tierra. Su especialidad son las epidemias, la Salud Pública y la Bioestadística, mater
- 09/11/2020
|
Matters of the Mind: Relationships and how to keep them real
- Relationships in life are important and there is a great sense of satisfaction we get from belonging to a tribe. The fun and laughter that the camaraderie brings literally gives us a huge kick in the form of endorphins. But, like with everything good, there is a flip side
- 09/11/2020
|
25 psychological tricks that will help you ace a job interview
|
Une neurobiologiste française d'Harvard touche le jackpot pour une surprenante découverte
- Aux Etats-Unis, la neurobiologiste française d'Harvard Catherine Dulac a gagné un prix scientifique doté de 3 millions de dollars pour avoir découvert les neurones de l'instinct parental. Elle donnera
- 09/10/2020
|
UK mathematician wins richest prize in academia
- Martin Hairer takes $3m Breakthrough prize for work a colleague said must have been done by aliens
- 09/10/2020
|
Worldwise: Chef Trisha Perez Kennealy’s Favorite Things
- ‘Joy of Cooking,’ a chef’s knife, and looking at the ocean from her home in Kennebunk, Maine
- 09/09/2020
|
Oxford Covid-19 vaccine trial participant undeterred by pause
- Man says he would continue with trial despite being worried about a second injection
- 09/09/2020
|
'It's a bummer': college students share what returning to campus is like right now
- CNBC Make It spoke with college students about what starting the academic year during Covid-19 is like right now.
- 09/08/2020
|
Cash Flow Doesn't Matter, Until It Does
- Investors young and old have had a great opportunity to watch the rise and fall of Nasdaq favorites this year.
- 09/08/2020
|
Michael Sandel: 'The populist backlash has been a revolt against the tyranny of merit'
- The philosopher believes the liberal left’s pursuit of meritocracy has betrayed the working classes. His new book argues for a politics centred on dignity
- 09/06/2020
|
Coronavirus update: Global cases climb above 26.4 million, and U.S. vaccine program’s head sees very low chance of vaccine by late October
- The number of confirmed cases of the coronavirus that causes COVID-19 world-wide rose above 26.4 million on Friday with the U.S. accounting for about a...
- 09/04/2020
|
Opinion | What COVID-19 and Black Lives Matter reveals about elite colleges
- Whom do wealthy private colleges and universities really serve? Let the autumn of our discontent begin.
- 09/01/2020
|
The High Cost Of Higher Education
- Letters on a possible crash in college-tuition costs, tech stock splits, and the Neuberger Berman Genesis fund
- 08/29/2020
|
Taking the racism out of capitalism isn’t good enough
- Woke capitalism, not racial capitalism, is the future, though it will not necessarily be any better for most people of color than its earlier, cruder version.
- 08/27/2020
|
Expand your mind with access to over 1,000 lectures from Tim Ferriss, Malcolm Gladwell, and more
- It depends on what field you're in — but you can improve in both areas with these deals on Big Think Edge
- 08/27/2020
|
Walmart, Starbucks and a growing number of U.S. companies set to give workers time off to vote
- A growing number of U.S. companies are pledging to give workers time off to vote in the presidential election this November, an effort that’s gaining steam...
- 08/27/2020
|
Sens. Warren, Smith press major labs over coronavirus testing delays as flu season approaches
- Many public health specialists and epidemiologists have repeatedly said that widespread and rapid testing for the coronavirus is critical to driving the U.S. response.
- 08/27/2020
|
Strangely, Harvard University Has These Gags to Thank For Facebook Stats Boost
- No, it was not hacked!
- 08/27/2020
|
CDC quietly revises coronavirus guidance to downplay importance of testing for asymptomatic people
- "This makes no sense. People without symptoms account for up to 50% of transmission," Dr. Leana Wen, the former health commissioner of Baltimore, said in a tweet. "We need MORE testing, not less."
- 08/26/2020
|
Opinion | Russia and the Never Trumpers
- In the collusion racket, too many pundits were ‘traitors to themselves.’
- 08/25/2020
|
Defense Department has invested $162 million to expand coronavirus testing capacity, but shortfalls remain
- The Department of Defense has spent one-third of its CARES Act and Defense Production Act money to address the coronavirus pandemic, but state testing still lags far behind, experts indicate.
- 08/25/2020
|
Chinese Diplomats Helped Military Scholars Visiting the U.S. Evade FBI Scrutiny, U.S. Says
- The U.S. closed the Chinese consulate in Houston and ordered China to remove the researchers after finding what officials say was an intelligence-gathering operation aided by diplomats to collect cutting-edge scientific research from American universities.
- 08/25/2020
|
Newsletter: China Is Catching Up
- Your daily economics newsletter from The Wall Street Journal.
- 08/25/2020
|
College students prepare to head back home a week into classes as coronavirus cases on campus climb
- "This was not expected at all, this was not foreseen," said Kyle Garcia, a 17-year-old freshman at the University of Notre Dame.
- 08/25/2020
|
THE UPSKILLING IMPERATIVE: How Learning Can Help Any Workforce Triumph Over Uncertainty
- “The Upskilling Imperative” book published by McGraw-Hill and authored by Shelley Osborne, VP of Learning at Udemy, launched today.
- 08/25/2020
|
New Thinking on Covid Lockdowns: They’re Overly Blunt and Costly
- Blanket business shutdowns—which the U.S. never tried before this pandemic—led to a deep recession. Economists and health experts say there may be a better way.
- 08/24/2020
|
Experts flag risks in India's use of rapid tests for virus
- The danger is that the tests may falsely clear many who are infected with COVID-19, contributing to new spread of the virus in hard-hit areas.
- 08/23/2020
|
